Ref: Duga AL, Ngongo N, Fallah MP, et al. Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa. BMJ Glob Health 2024;9:e015445. doi:10.1136/ bmjgh-2024-015445
Dear E-druggers,
In this manuscript: Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa | BMJ Global Health, Duga and colleagues reflect on how to ensure a more confident and efficient rollout of malaria vaccines, leveraging the experiences of existing systems and of COVID-19 vaccine safety surveillance. This is an important policy issue: as stated by the Authors, “despite the critical role of pharmacovigilance in providing timely and accurate data on vaccine safety and influencing data-driven decision-making, it frequently continues to be overlooked in the context of global health”; and “given the current heterogeneous situation of pharmacovigilance in different African countries, improving capacity in countries introducing malaria vaccines should be given the highest priority”.
Have a nice reading,
Raffaella Ravinetto
Professor in Pharmaceutical Public Health
Institute of Tropical Medicine, Belgium